Monday, September 14, 2026

Is Myeolgong Tteokbokki Truly 100% Korean? Controversy Over Ingredients Sparks Debate

Kim Sang-hyun defends Myeolgong Tteokbokki against ingredient criticism, asserting domestic sourcing while addressing political backlash.

North Korea Condemns U.S.-Led Military Drills, Warns of Escalating Regional Tensions

South Korea, U.S., and Japan conducted joint military exercises, prompting North Korea to demand a halt and criticize rising tensions.

THE END IS HERE? North Korea’s Regime Is CRUMBLING—Who Controls Kim’s NUCLEAR WEAPONS Now?!

South Korea expresses condolences for Kim Yong-nam's passing, highlighting his role in inter-Korean dialogue during the 2018 Olympics.

Tag: NSCLC

AstraZeneca Highlights Decade of Tagrisso Progress in EGFR Mutation-Positive Lung Cancer Care

Tagrisso has revolutionized NSCLC treatment in Korea, expanding indications and improving survival rates over the past decade.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

A New Era in Precision Oncology—Lunit Unveils 7 AI-Driven Cancer Studies at AACR 2025

Lunit will present AI biomarker studies at AACR 2025, focusing on rare cancers and improving treatment strategies using AI analysis.

Top News

- Our Sponsors Ad -

Follow us